Diabetes mellitus-Definition, classification, diagnosis, screening and prevention (Update 2019)
Semaglutide GLP-1 tends to be well tolerated and exhibits side effects that are only mild to moderate in most cases
doi: 10.3322/caac.21446 10 BallehaninnaUKChamberlainRS
This medication is typically intended for short-term usegenerally a few weeks, up to 12 weeksdue to safety considerations such as increased heart rate, elevated blood pressure, insomnia, and the potential for dependence
The Phase 3 programme , understood to be known as the TRIUMPH trials, is now underway and is evaluating retatrutide across broader and more diverse patient populations, including individuals with: Obesity without type 2 diabetes Obesity with type 2 diabetes Obesity-related cardiovascular disease Metabolic dysfunction-associated steatohepatitis (MASH) Readers seeking the most current information on trial status, registered populations, and endpoints are encouraged to consult ClinicalTrials.gov directly, where Phase 3 trial registrations for retatrutide can be found
This means it narrows your blood vessels, reducing blood flow throughout the body